AcelRx Pharmaceuticals

The US Patent and Trademark Office Has Issued Two Additional Patents
Nov 28, 2012
The US Patent and Trademark Office (USPTO) has issued two additional patents to AcelRx Pharmaceuticals' sufentanil NanoTab pain products. The patent entitled Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment ...

Tags: AcelRx Pharmaceuticals, NanoTab pain products, two additional patents
USPTO Has Granted Two New Patents Including Patent No.8,252,328 and Patent No.8,252,329
Nov 28, 2012
The US Patent and Trademark Office(USPTO)has granted two new patents including Patent No.8,252,328 and Patent No.8,252,329 to AcelRx Pharmaceuticals'small-volume oral transmucosal dosage forms. The 8,252,328 patent covers delivery of ...

Tags: two new patents, 328, Patent No.8, 252, 329, AcelRx Pharmaceuticals
The US Patent Was Granted to AcelRx for Its Sufentanil Nanotab Based Products
Jun 21, 2012
AcelRx Pharmaceuticals has received a US patent which provides intellectual property protection for sufentanil NanoTab based products through late 2030. The patent entitled, Small-Volume Oral Transmucosal Dosage Forms, describes a method ...

Tags: US patent, clinical technology, pharmaceutical product